Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Cell cycle Kinases/phosphatases Cdks

Recombinant human ICK protein (ab101774)

Recombinant human ICK protein (ab101774)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: Baculovirus
  • Purity: > 75% SDS-PAGE
  • Active: Yes
  • Suitable for: WB, Functional Studies, SDS-PAGE

You may also be interested in

Product image
Recombinant human Cdk4 + Cyclin D1 protein (ab55695)
Product image
Human CDK10 knockout HEK-293T cell lysate (ab258350)
Product image
Anti-CDK1 antibody [CDK1/873] - BSA and Azide free (ab213118)
Product image
Anti-CDC2L6 antibody - N-terminal (ab198843)

Description

  • Product name

    Recombinant human ICK protein
  • Biological activity

    The Specific activity of ab101774 was determined to be 4.8 nmol/min/mg.
  • Purity

    > 75 % SDS-PAGE.
    Purity was determined to be >75% by densitometry.
  • Expression system

    Baculovirus
  • Accession

    Q9UPZ9
  • Protein length

    Full length protein
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human
    • Predicted molecular weight

      98 kDa including tags
    • Amino acids

      1 to 632

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 7.50
    Constituents: 0.307% Glutathione, 0.00174% PMSF, 0.00385% DTT, 0.79% Tris HCl, 0.00292% EDTA, 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

Images

  • Functional Studies - Recombinant human ICK protein (ab101774)
    Functional Studies - Recombinant human ICK protein (ab101774)
    The specific activity of ICK (ab101774) was determined to be 4.8 nmol/min/mg as per activity assay protocol
  • SDS-PAGE - Recombinant human ICK protein (ab101774)
    SDS-PAGE - Recombinant human ICK protein (ab101774)
    SDS PAGE analysis of ab101774
  • SDS-PAGE - Recombinant human ICK protein (ab101774)
    SDS-PAGE - Recombinant human ICK protein (ab101774)
    SDS-PAGE analysis of ab101774.
  • Functional Studies - Recombinant human ICK protein (ab101774)
    Functional Studies - Recombinant human ICK protein (ab101774)
    The Specific activity of ab101774 was determined to be 4.8 nmol/min/mg.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Ubiquitin antibody [EPR8589] - BSA and Azide free (ab248778)

  •  
  • Product image

    Anti-Apolipoprotein CIV antibody (ab232710)

  •  
  • Product image

    Anti-Sarcomeric Alpha Actinin antibody (ab72592)

  •  
  • Product image

    redFluor™ 710 Anti-CD11b antibody [M1/70] (ab253091)

  •  
  • Product image

    Anti-Cannabinoid Receptor I antibody (ab40860)

  •  
  • Human SFPQ Blocking peptide  (ab39323)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.